SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-24-000359
Filing Date
2024-03-11
Accepted
2024-03-11 16:33:21
Documents
20
Period of Report
2024-03-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 35495
2 LEGAL OPINION ex5x1.htm EX-5.1 8673
3 UNDERWRITING AGREEMENT DATED MARCH 7, 2024 ex10x1.htm EX-10.1 265298
4 EXHIBIT 99.1 ex99x1.htm EX-99.1 6762
5 EXHIBIT 99.2 ex99x2.htm EX-99.2 6786
6 GRAPHIC image_002.jpg GRAPHIC 7525
  Complete submission text file 0001079973-24-000359.txt   630617

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE scpx-20240307.xsd EX-101.SCH 3549
8 XBRL DEFINITION FILE scpx-20240307_def.xml EX-101.DEF 26579
9 XBRL LABEL FILE scpx-20240307_lab.xml EX-101.LAB 36527
10 XBRL PRESENTATION FILE scpx-20240307_pre.xml EX-101.PRE 25203
21 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 5436
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 24738545
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)